Quantcast

Latest Atrial septal defect Stories

2014-09-15 08:28:40

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Heart Defect Closure Devices Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Heart defect closure devices are used for the treatment of several CHDs. The heart closure devices help when closing the ostium/ hole/ deficiency in the structure of the heart present in the septal walls or blood vessels that occurs in the patients with CHDs. CHD is an...

2014-08-25 16:23:51

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Atrial Septal Defect Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/652978/Atrial-Septal-Defect-Global-Clinical-Trials-Review-H2-2014.htmlAtrial Septal Defect Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Atrial Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Atrial Septal Defect clinical trial...

2014-08-11 23:07:45

Zoloft Birth Defect Lawsuits Filed Allege SSRI Antidepressant Caused Children to Be Born with Various Congenital Malformations, Including Atrial Septal Defect; Persistent Pulmonary Hypertension of the Newborn, Neural Tube Defects, and Craniofacial Defects Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 11, 2014 Wright & Schulte LLC, a nationally-recognized law firm representing plaintiffs in Zoloft lawsuits, notes that 13 new claims were recently filed in West Virginia...

2014-07-09 23:03:50

NobleStitch 1 year results receive positive reviews from physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt. Fountain Valley, CA (PRWEB) July 09, 2014 Nobles Medical Technologies II (NMT2) today announced that Dr. Michael Mullen (Consultant Cardiologist at the University College Hospital and Member of the NMT2 clinical Advisory Board) presented positive results for the 1-year follow up of patients treated with NobleStitch EL PFO Closure System. NMT2...

2014-07-07 23:07:45

HeartStitch TA Receives Strong Reviews from Physcians at Congenital & Structural Interventions Congress (CSI) in Frankfurt Fountain Valley, CA (PRWEB) July 07, 2014 HeartStitch, Inc. today announced that Prof. Anthony Nobles, CEO of HeartStitch, presented final results of 148 Porcine Transapical Closures treated with HeartStitch TA Access & Closure System. HeartStitch received positive reviews from cardiologists and cardiac surgeons including members of the panel as well as...

2014-06-19 23:18:18

Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. Fountain Valley, CA (PRWEB) June 19, 2014 Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. The patient, a nurse/ administrator from the hospital and rehabilitation center in Linkoping, who has suffered from stroke and migraine was being treated with aggressive medication Warfarin (a...

2014-05-16 23:07:41

Nobles Medical Technologies II treats first US patient with NobleStitch EL PFO Closure Device. Fountain Valley, CA (PRWEB) May 16, 2014 Nobles Medical Technologies II (NMT2) today announced that its first American patient has had a successful PFO closure. John Wyall from Orem, Utah has suffered from stroke, aura, and severe chronic fatigue that has worsened in the last few years to the point that he has been bedfast for 14 to 18 hours a day for the last year and a half and unable to do...

2014-05-16 23:07:31

Nobles Medical Technologies II today announced that it has hired Elvia Contreras-Lopez as Director of Regulatory Affairs and Quality Assurance. Fountain Valley, California (PRWEB) May 16, 2014 Elvia has more than 23 years experience in Regulatory Affairs and Quality Assurance. She has extensive experience in US and international design controls and procedures. She has drafted and worked on PMA’s and 510K’s as well as CE mark for several products working for St. Jude Medical, Cannon...

2014-04-29 23:07:45

Nobles Medical Technologies II today announced that it has received another Japanese Patent for its NobleStitch Technology. The patent is for the Suturing Devices and Methods for Closing a Patent Foramen Ovale (PFO) and shows the broad coverage of our method and apparatus for PFO Closure expanding to markets around the world. Fountain Valley, CA (PRWEB) April 29, 2014 Ben Brosch, President of NMT2 and co-inventor on the issued patent, commented, “We strive to protect our inventions with...

2014-04-26 23:03:01

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has officially launched sales in Sweden for its NobleStitch EL PFO Closure System. NMT2 launched sales initially in Germany and the UK and will now be expanding this month into Sweden. Fountain Valley, California (PRWEB) April 26, 2014 Following a successful meeting at the Congress of Structural Interventions (CSI) congress in Frankfurt last June NMT2 received significant inquiries to bring its PFO technology to new...


Latest Atrial septal defect Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related